New imaging methods for detecting diabetic retinopathy
Official title: Novel ultrahigh speed swept source OCT angiography methods in diabetic retinopathy
Funded at Massachusetts Institute of Technology · NIH-10883696 · Data updated 2026-11-12
This study is testing a new imaging technique to help doctors spot and track diabetic retinopathy early, so patients can get the right treatment sooner and protect their vision.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts Institute of Technology NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project start | August 1, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2024 |
| Award (this year) | $485,932 |
| NIH project number | 5R01EY034080-02 |
| Project ID | NIH-10883696 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals with diabetes who are at risk of developing diabetic retinopathy.
✕Less likely to help
Patients without diabetes or those who do not have any signs of diabetic retinopathy may not benefit from this research.
What this research studies
This research focuses on developing advanced imaging techniques to detect and monitor diabetic retinopathy, a condition that can lead to blindness. By utilizing ultrahigh speed swept-source optical coherence tomography (OCT), the project aims to create detailed images of the retinal blood vessels and assess blood flow at the capillary level. This innovative approach will help in early detection of vision-threatening changes, allowing for timely treatment and better management of the disease. Patients will benefit from improved diagnostic tools that can provide objective assessments of their retinal health.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection and better management of diabetic retinopathy, potentially preserving vision for many patients.
How similar studies have gone: Previous research has shown promise in using advanced imaging techniques for retinal assessment, indicating that this approach could lead to significant advancements in diabetic retinopathy management.
Where this research is happening
-
Massachusetts Institute of Technology
Cambridge, United States Active
Researchers
- Principal investigator: Fujimoto, James G — Massachusetts Institute of Technology
- Study coordinator: Fujimoto, James G
Related research
Other NIH-funded projects on the same topics.
-
Integrative multi-omics to understand diabetic retinopathy
A doctor-scientist team will study blood markers and genetic signals to see why diabetic retinopathy happens and how it affects Hispanic/Latino people.
-
Smartphone retinal imaging for diabetic eye disease in Egypt
This project uses a low-cost smartphone camera and AI to find signs of diabetic eye damage in adults with diabetes in Egypt.
-
Retinal Cell Loss in Diabetic Retinopathy
This project looks at how mitochondrial problems and a specific kind of cell death called ferroptosis may cause retinal cells to die in people with diabetes-related eye disease.
-
Redox-triggered REDD1 blockers for diabetic retinopathy
A research project tests new ways to stop a stress protein (REDD1) from causing vision problems in people with diabetic retinopathy.
-
Ultrafast eye imaging to detect and track diabetic retinopathy
A doctor-science team is developing ultra-fast eye scans to better see tiny blood vessels in people with diabetic retinopathy, helping catch changes early and guide treatment.
-
Practical device to automatically track abnormal retinal blood vessel growth in diabetic eye disease
A new, easier-to-use imaging device aims to automatically detect and monitor abnormal retinal blood vessel growth in people with diabetic retinopathy.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.